Towards Improved Diagnostics for Suspected Platelet Function Disorders
NCT05985668 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 140
Last updated 2023-12-04
Summary
This study aims to improve platelet function testing during bleeding investigations. To this end, the study will evaluate the diagnostic accuracy of novel platelet function tests in patients with confirmed or suspected platelet function disorders. Study participants will be recruited from patients that are referred to or treated at the Coagulation Unit, Karolinska University Hospital, and Pediatric Coagulation Unit, Astrid Lingren Children's Hospital.
Conditions
- Platelet Function Disorder
- Platelet Disorder
- Thrombocytopathy
Sponsors & Collaborators
- collaborator OTHER
-
Region Stockholm
lead OTHER_GOV
Eligibility
- Min Age
- 12 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-09-05
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- Sweden
Study Locations
More Related Trials
-
Bleeding Prediction in Thrombocytopenia
NCT02306044 ·Status: COMPLETED
-
Cold Versus Room Temperature Storage of Platelets for Bleeding in Hematologic Malignancy - a Pilot Trial
NCT05820126 ·Status: RECRUITING ·Phase: PHASE2
-
Assesment of the Functional Activity of Platelets for the Differential Diagnosis of Thrombocytopathies
NCT05654766 ·Status: UNKNOWN
-
Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS)
NCT03469661 ·Status: COMPLETED
-
Bleeding In Thrombocytopenia Explained
NCT03505086 ·Status: RECRUITING
-
Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker
NCT04003220 ·Status: UNKNOWN
-
Optimizing the Diagnosis of Heparin Induced Thrombocytopenia
NCT03148912 ·Status: UNKNOWN ·Phase: NA
-
Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induced Thrombocytopenia
NCT06033300 ·Status: RECRUITING ·Phase: NA
-
Italian Study for Congenital Platelet Disorders
NCT06691581 ·Status: ACTIVE_NOT_RECRUITING
-
Study to Reveal if Fibrinogen Treatment Effects Blood Clotting Better Than a Platelet Transfusion
NCT01955811 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess Platelet Dysfunction With Verify Now Assay
NCT01167218 ·Status: COMPLETED
-
Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia
NCT06824727 ·Status: COMPLETED
-
A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease
NCT05193201 ·Status: UNKNOWN ·Phase: PHASE1
-
The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP
NCT03377439 ·Status: UNKNOWN
-
Prevalence of Thyroid Disorders in Patients With Immune Thrombocytopenic Purpura and Its Impact on Treatment
NCT07059910 ·Status: NOT_YET_RECRUITING
-
National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients
NCT07268898 ·Status: NOT_YET_RECRUITING
-
Diagnostic of Chronic Thrombocytopenia
NCT04071496 ·Status: COMPLETED
-
The PROLONG Trial - Rituximab Maintenance Therapy in ITP
NCT03010202 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Eltrombopag for Refractory Thrombocytopenia Associated With Connective Tissue Disease
NCT06458803 ·Status: COMPLETED
-
Platelet Reactivity In Patients With Nuisance Bleeding On A Thienopyridine
NCT01152229 ·Status: COMPLETED
-
The Serum Lipid Profiles in ITP: a Retrospective Study
NCT05095896 ·Status: COMPLETED
-
The Study of Different Dose Rituximab in the Treatment of ITP
NCT03258866 ·Status: COMPLETED ·Phase: PHASE4
-
Risk Factors and Predictors of Thrombosis in Myeloprolferative Neoplasms
NCT03599700 ·Status: UNKNOWN
-
PLATELET Function Assay With Flow Imaging on ImageSTREAM Cytometer
NCT04842760 ·Status: UNKNOWN
-
Drug Etiology of Aplastic Anemia and Related Dyscrasias
NCT00005302 ·Status: COMPLETED